These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 8732667)

  • 1. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
    Shain SA; Sarić T; Ke LD; Nannen D; Yoas S
    Cell Growth Differ; 1996 May; 7(5):573-86. PubMed ID: 8732667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor-2 and TPA enhance prostate-cancer-cell proliferation and activate members of the Ras and PKC signal transduction pathways.
    Hrzenjak M; Shain SA
    Recept Signal Transduct; 1997; 7(4):207-19. PubMed ID: 9633822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
    Shain SA
    Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neither fibroblast growth factor-1 nor fibroblast growth factor-2 is an androgen receptor coactivator in androgen-resistant prostate cancer.
    Shain SA
    Mol Urol; 2001; 5(3):121-30. PubMed ID: 11690559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in responsiveness of clonally derived AXC/SSh rat prostate cancer cells to secreted or prototypic mitogens.
    Shain SA; Koger JD
    Cancer Res; 1989 Jul; 49(14):3898-903. PubMed ID: 2786746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat prostate cancer cell line-specific production and apparent secretion of heparin-binding growth factors.
    Shain SA; Ke LD; Wong G; Karaganis AG
    Cell Growth Differ; 1992 Apr; 3(4):249-58. PubMed ID: 1381214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.
    Pass HI; Mew DJ; Carbone M; Matthews WA; Donington JS; Baserga R; Walker CL; Resnicoff M; Steinberg SM
    Cancer Res; 1996 Sep; 56(17):4044-8. PubMed ID: 8752177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
    Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
    Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line.
    Maret A; Galy B; Arnaud E; Bayard F; Prats H
    Cancer Res; 1995 Nov; 55(21):5075-9. PubMed ID: 7585554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of aFGF expression in quiescent cells is related to cell survival.
    Renaud F; Oliver L; Desset S; Tassin J; Romquin N; Courtois Y; Laurent M
    J Cell Physiol; 1994 Mar; 158(3):435-43. PubMed ID: 7510293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of overexpressing fibroblast growth factor 2 protein isoforms in osteoblastic ROS 17/2.8 cells.
    Xiao L; Liu P; Sobue T; Lichtler A; Coffin JD; Hurley MM
    J Cell Biochem; 2003 Aug; 89(6):1291-301. PubMed ID: 12898525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
    Vilenchik M; Raffo AJ; Benimetskaya L; Shames D; Stein CA
    Cancer Res; 2002 Apr; 62(7):2175-83. PubMed ID: 11929841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic fibroblast growth factor and receptor expression in human ovarian cancer.
    Crickard K; Gross JL; Crickard U; Yoonessi M; Lele S; Herblin WF; Eidsvoog K
    Gynecol Oncol; 1994 Nov; 55(2):277-84. PubMed ID: 7959296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fibroblast growth factor-2 antisense gene inhibits nuclear accumulation of FGF-2 and delays cell cycle progression in C6 glioma cells.
    Baguma-Nibasheka M; Li AW; Murphy PR
    Mol Cell Endocrinol; 2007 Mar; 267(1-2):127-36. PubMed ID: 17306451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
    Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
    Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.
    Nelson JB; Chan-Tack K; Hedican SP; Magnuson SR; Opgenorth TJ; Bova GS; Simons JW
    Cancer Res; 1996 Feb; 56(4):663-8. PubMed ID: 8630991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation.
    Wieder R; Fenig E; Wang H; Wang Q; Paglin S; Menzel T; Gabrilove J; Fuks Z; Yahalom J
    J Cell Physiol; 1998 Dec; 177(3):411-25. PubMed ID: 9808150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.